Irinotecan-Associated Dysarthria in Patients with Pancreatic Cancer: A Single Site Experience

Related articles

27 Jul 2020 : Clinical Research

Clinical Characteristics and Prognosis of Osteoclast-like Giant Cell Tumors of the Pancreas Compared with Pancreatic Adenocarcinomas: A Population-Based Study

Mingfang Xu, Wei Chen, [...] Dong Wang, Mao Nie - Show fewer authors

DOI: 10.12659/MSM.922585

09 Mar 2018 : Laboratory Research

Overexpression of Nitrogen Permease Regulator Like-2 (NPRL2) Enhances Sensitivity to Irinotecan (CPT-11) in Colon Cancer Cells by Activating the DNA Damage Checkpoint Pathway

Shasha Liu, Bingrong Liu

DOI: 10.12659/MSM.909186

24 Apr 2011

Palliative first-line therapy with weekly high-dose 5-fluorouracil and sodium folinic acid as a 24-hour infusion (AIO regimen) combined with weekly irinotecan in patients with metastatic adenocarcinoma of the stomach or esophagogastric junction followed by secondary metastatic resection after downsizing

Kathrin Koucky, Axel Wein, [...] Peter C. Konturek, Heinz Albrecht, Udo Reulbach, Gudrun Mannlein, Kerstin Wolff, Nicola Ostermeier, Dagmar Busse, Henriette Golcher, Claus Schildberg, Rolf Janka, Werner Hohenberger, Eckhart G. Hahn, Jurgen Siebler, Markus F. Neurath, Frank Boxberger - Show fewer authors

DOI: 10.12659/MSM.881764

15 Sep 2010

Cerebral Infarcts and growing cerebral metastasis traced to an unusual source: Paradoxical embolism of renal cell carcinoma

Marco A. Gonzalez, Melanie Hiovani, [...] Thomas V. Bilfinger - Show fewer authors